BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matson V, Chervin CS, Gajewski TF. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy. Gastroenterology 2021;160:600-13. [PMID: 33253684 DOI: 10.1053/j.gastro.2020.11.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Park CH, Hong C, Lee A, Sung J, Hwang TH. Multi-omics reveals microbiome, host gene expression, and immune landscape in gastric carcinogenesis. iScience 2022;25:103956. [DOI: 10.1016/j.isci.2022.103956] [Reference Citation Analysis]
2 Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguère T. Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature. Cancer 2021. [PMID: 34494666 DOI: 10.1002/cncr.33893] [Reference Citation Analysis]
3 Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
4 Yuan C, Zhao X, Wangmo D, Alshareef D, Gates TJ, Subramanian S. Tumor models to assess immune response and tumor-microbiome interactions in colorectal cancer. Pharmacol Ther 2021;:107981. [PMID: 34480964 DOI: 10.1016/j.pharmthera.2021.107981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Thrastardottir TO, Copeland VJ, Constantinou C. The Association Between the Gut Microbiome, Nutritional Habits, Antibiotics, and Gastric Cancer: a Scoping Review. Curr Nutr Rep 2022. [PMID: 35020173 DOI: 10.1007/s13668-021-00391-z] [Reference Citation Analysis]
6 Lam KK, Thean LF, Cheah PY. Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention. Int J Biochem Cell Biol 2021;137:106032. [PMID: 34182137 DOI: 10.1016/j.biocel.2021.106032] [Reference Citation Analysis]
7 An Y, Zhang W, Liu T, Wang B, Cao H. The intratumoural microbiota in cancer: new insights from inside. Biochim Biophys Acta Rev Cancer 2021;1876:188626. [PMID: 34520804 DOI: 10.1016/j.bbcan.2021.188626] [Reference Citation Analysis]
8 Zarei A, Javid H, Sanjarian S, Senemar S, Zarei H. Metagenomics studies for the diagnosis and treatment of prostate cancer. Prostate 2021. [PMID: 34855234 DOI: 10.1002/pros.24276] [Reference Citation Analysis]
9 Wang Y, Ku W, Liu C, Cheng Y, Chien C, Chang K, Huang C. Supplementation of Probiotic Butyricicoccus pullicaecorum Mediates Anticancer Effect on Bladder Urothelial Cells by Regulating Butyrate-Responsive Molecular Signatures. Diagnostics 2021;11:2270. [DOI: 10.3390/diagnostics11122270] [Reference Citation Analysis]
10 Läsche M, Urban H, Gallwas J, Gründker C. HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review. Cells 2021;10:714. [PMID: 33807087 DOI: 10.3390/cells10030714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Barcena-Varela M, Lujambio A. The Endless Sources of Hepatocellular Carcinoma Heterogeneity. Cancers (Basel) 2021;13:2621. [PMID: 34073538 DOI: 10.3390/cancers13112621] [Reference Citation Analysis]
12 Shi Y, Zheng H, Wang M, Ding S. Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention. Helicobacter 2022;:e12878. [PMID: 35112435 DOI: 10.1111/hel.12878] [Reference Citation Analysis]
13 Mao J, Wang D, Long J, Yang X, Lin J, Song Y, Xie F, Xun Z, Wang Y, Wang Y, Li Y, Sun H, Xue J, Song Y, Zuo B, Zhang J, Bian J, Zhang T, Yang X, Zhang L, Sang X, Zhao H. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers. J Immunother Cancer 2021;9:e003334. [PMID: 34873013 DOI: 10.1136/jitc-2021-003334] [Reference Citation Analysis]
14 Majumder S, Shivaji UN, Kasturi R, Sigamani A, Ghosh S, Iacucci M. Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives. World J Gastrointest Oncol 2022; 14(3): 547-567 [DOI: 10.4251/wjgo.v14.i3.547] [Reference Citation Analysis]
15 Lu H, Wang Q, Liu W, Wen Z, Li Y. Precision strategies for cancer treatment by modifying the tumor-related bacteria. Appl Microbiol Biotechnol 2021;105:6183-97. [PMID: 34402938 DOI: 10.1007/s00253-021-11491-9] [Reference Citation Analysis]
16 Sampsell K, Hao D, Reimer RA. The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship. Int J Mol Sci 2020;21:E9239. [PMID: 33287442 DOI: 10.3390/ijms21239239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 McCormick BA, Chang EB. The Gut Microbiome: Reaching the Promise Through Discovery- Advancing Knowledge and Discovery of the Gut Microbiome in the Age of Precision Medicine. Gastroenterology 2021;160:479-82. [PMID: 33382981 DOI: 10.1053/j.gastro.2020.12.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Wu M, Bai J, Ma C, Wei J, Du X. The Role of Gut Microbiota in Tumor Immunotherapy. J Immunol Res 2021;2021:5061570. [PMID: 34485534 DOI: 10.1155/2021/5061570] [Reference Citation Analysis]
19 Alon-Maimon T, Mandelboim O, Bachrach G. Fusobacterium nucleatum and cancer. Periodontol 2000 2022. [PMID: 35244982 DOI: 10.1111/prd.12426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sexton RE, Uddin MH, Bannoura S, Khan HY, Mzannar Y, Li Y, Aboukameel A, Al-Hallak MN, Al-Share B, Mohamed A, El-Rayes B, Azmi AS. Connecting the Human Microbiome and Pancreatic Cancer. Cancer Metastasis Rev 2022. [PMID: 35366155 DOI: 10.1007/s10555-022-10022-w] [Reference Citation Analysis]
21 Sakowska J, Arcimowicz Ł, Jankowiak M, Papak I, Markiewicz A, Dziubek K, Kurkowiak M, Kote S, Kaźmierczak-siedlecka K, Połom K, Marek-trzonkowska N, Trzonkowski P. Autoimmunity and Cancer—Two Sides of the Same Coin. Front Immunol 2022;13:793234. [DOI: 10.3389/fimmu.2022.793234] [Reference Citation Analysis]
22 Zhu P, Lu T, Chen Z, Liu B, Fan D, Li C, Wu J, He L, Zhu X, Du Y, Tian Y, Fan Z. 5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis. Neuron 2022:S0896-6273(22)00369-5. [PMID: 35550066 DOI: 10.1016/j.neuron.2022.04.024] [Reference Citation Analysis]
23 Li J, Zhang AH, Wu FF, Wang XJ. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Front Oncol 2022;12:841552. [PMID: 35223525 DOI: 10.3389/fonc.2022.841552] [Reference Citation Analysis]
24 Pagan L, Ederveen RAM, Huisman BW, Schoones JW, Zwittink RD, Schuren FHJ, Rissmann R, Piek JMJ, van Poelgeest MIE. The Human Vulvar Microbiome: A Systematic Review. Microorganisms 2021;9:2568. [PMID: 34946169 DOI: 10.3390/microorganisms9122568] [Reference Citation Analysis]
25 Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Sampani K. Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochem Pharmacol 2021;193:114809. [PMID: 34673016 DOI: 10.1016/j.bcp.2021.114809] [Reference Citation Analysis]
26 Wang Y, Wang Y, Wang J. A comprehensive analysis of intratumor microbiome in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2022. [PMID: 35122129 DOI: 10.1007/s00405-022-07284-z] [Reference Citation Analysis]